Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8401 to 8450 of 8900 results

  1. Health app: ChatHealth communication platform in school nursing services (MIB130)

    The health app briefing on ChatHealth communication platform in school nursing services has been withdrawn.

    Withdrawn advice

  2. Health app: GDm-Health for people with gestational diabetes (MIB131)

    This health app briefing on GDm-Health for people with gestational diabetes has been withdrawn.

    Withdrawn advice

  3. Point-of-care creatinine tests before contrast-enhanced imaging (MIB136)

    This advice has been replaced by NICE HealthTech guidance 530.

    Withdrawn advice

  4. Plus Sutures for preventing surgical site infection (MIB204)

    This advice has been updated and replaced by NICE healthtech guidance guidance 586.

    Withdrawn advice

  5. EarlyCDT-Lung for cancer risk classification of indeterminate pulmonary nodules (MIB209)

    This advice has been updated and replaced by NICE healthtech guidance 611.

    Withdrawn advice

  6. Reveal LINQ insertable cardiac monitor to detect atrial fibrillation after cryptogenic stroke (MIB141)

    This advice has been updated and replaced by NICE healthtech guidance 553.

    Withdrawn advice

  7. Curos disinfecting cap for needleless connectors (MIB143)

    This advice has been updated and replaced by NICE medical technologies guidance 44.

    Withdrawn advice

  8. Point-of-care diagnostic testing in primary care for strep A infection in sore throat (MIB145)

    This advice has been updated and replaced by NICE HealthTech guidance 531.

    Withdrawn advice

  9. QAngio XA 3D/QFR imaging software for assessing coronary obstructions (MIB146)

    This advice has been updated and replaced by NICE healthtech guidance 571.

    Withdrawn advice

  10. PICO negative pressure wound therapy for closed surgical incision wounds (MIB149)

    This advice has been updated and replaced by NICE medical technologies guidance 43.

    Withdrawn advice

  11. Alpha-Stim AID for anxiety (MIB193)

    This advice has been updated and replaced by NICE healthtech guidance 570.

    Withdrawn advice

  12. DyeVert for reducing contrast media in coronary and peripheral angiography (MIB196)

    This advice has been updated and replaced by NICE healthtech guidance 594.

    Withdrawn advice

  13. Leukomed Sorbact for preventing surgical site infection (MIB197)

    This advice has been updated and replaced by NICE healthtech guidance 567.

    Withdrawn advice

  14. The ZedScan as an adjunct to colposcopy in women with suspected cervical intra‑epithelial neoplasia (MIB20)

    This advice has been updated and replaced by NICE diagnostics guidance 32.

    Withdrawn advice

  15. LiverMultiScan for liver disease (MIB181)

    This advice has been updated and replaced by NICE healthtech guidance 655.

    Withdrawn advice

  16. SEM Scanner for pressure ulcer prevention (MIB182)

    This advice has been updated and replaced by NICE medical technologies guidance 51.

    Withdrawn advice

  17. Peezy Midstream for urine collection (MIB183)

    NICE has withdrawn the med tech innovation briefing (MIB) on Peezy Midstream for urine collection.

    Withdrawn advice

  18. Danis stent for acute oesophageal variceal bleeds (MIB185)

    This advice has been updated and replaced by NICE healthtech guidance 574.

    Withdrawn advice

  19. Endo-SPONGE for colorectal anastomotic leakage (MIB188)

    This advice has been updated and replaced by NICE healthtech guidance 605.

    Withdrawn advice

  20. The V.A.C. Veraflo Therapy system for infected wounds (MIB189)

    This advice has been updated and replaced by NICE healthtech guidance 566.

    Withdrawn advice

  21. UroShield for preventing catheter-associated urinary tract infections (MIB191)

    This advice has been updated and replaced by NICE healthtech guidance 620.

    Withdrawn advice

  22. Diabetes: statins for primary prevention of CVD (T2DM and 10% risk) (IND182)

    This guidance has been updated and replaced by NICE indicator 274.

    Withdrawn indicator

  23. Atrial fibrillation: pulse rhythm assessment in people at risk (IND168)

    This indicator has been withdrawn following National Screening Committee recommendations and ongoing research.

    Withdrawn indicator

  24. Weight management: BMI calculation in preceding 5 years (IND167)

    This indicator has been withdrawn following discussions with the National Screening Committee.

    Withdrawn indicator

  25. Diabetes: T1DM and statins (IND166)

    This guidance has been updated and replaced by NICE indicator 277.

    Withdrawn indicator

  26. Cardiovascular disease prevention: statins for people newly diagnosed with hypertension or T2DM (IND162)

    This indicator has been updated and replaced by NICE indicator 287.

    Withdrawn indicator

  27. Weight management: BMI recording (long-term conditions) (IND151)

    This indicator has been updated and replaced by NICE indicator 320.

    Withdrawn indicator

  28. Diabetes: blood pressure (without moderate or severe frailty) (IND236)

    This indicator has been updated and replaced by NICE indicator 249.

    Withdrawn indicator

  29. Diabetes: annual psychological assessment (children) (IND57)

    This indicator has been updated and replaced by NICE indicator 313 and NICE indicator 314.

    Withdrawn indicator

  30. Diabetes: thyroid disease screening (children) (IND56)

    This indicator has been updated and replaced by NICE indicator 312.

    Withdrawn indicator

  31. Diabetes: annual smoking status (children) (IND55)

    This indicator has been updated and replaced by NICE indicator 310 and NICE indicator 311.

    Withdrawn indicator

  32. Diabetes: annual foot examination (children) (IND54)

    This indicator has been updated and replaced by NICE indicator 308 and NICE indicator 309.

    Withdrawn indicator

  33. Diabetes: annual eye screening (children) (IND53)

    This indicator has been updated and replaced by NICE indicator 306 and NICE indicator 307.

    Withdrawn indicator

  34. Diabetes: annual urinary albumin (children) (IND52)

    This indicator has been updated and replaced by NICE indicator 304 and NICE indicator 305.

    Withdrawn indicator

  35. Diabetes: annual BMI (children) (IND50)

    This indicator has been updated and replaced by NICE indicator 300 and NICE indicator 301.

    Withdrawn indicator

  36. Diabetes: annual blood pressure (children) (IND51)

    This indicator has been updated and replaced by NICE indicator 302 and NICE indicator 303.

    Withdrawn indicator

  37. Diabetes: annual HbA1c (children) (IND49)

    This indicator has been updated and replaced by NICE indicator 298 and NICE indicator 299.

    Withdrawn indicator

  38. Diabetes: annual care processes (children) (IND48)

    This indicator has been updated and replaced by NICE indicator 296 and NICE indicator 297.

    Withdrawn indicator

  39. Cardiovascular disease prevention: cholesterol treatment target (secondary prevention) (IND268)

    This indicator has been updated and replaced by NICE indicator 278.

    Withdrawn indicator

  40. Kidney conditions: CKD and SGLT2 inhibitors (IND262)

    This indicator has been updated and replaced by NICE indicator 322.

    Withdrawn indicator

  41. Multiple long-term conditions: falls prevention advice (IND209)

    This indicator has been removed following the publication of NICE guideline NG249.

    Withdrawn indicator

  42. Heart failure: beta blockers (IND194)

    This indicator has been updated and replaced by NICE indicator 317.

    Withdrawn indicator

  43. Heart Failure: ACEi or ARBs (IND193)

    This indicator has been updated and replaced by NICE indicator 317.

    Withdrawn indicator

  44. Asthma: annual review (IND188)

    This guidance has been updated and replaced by NICE indicator 273.

    Withdrawn indicator

  45. Asthma: objective tests (IND187)

    This guidance has been updated and replaced by NICE indicator 272.

    Withdrawn indicator

  46. Diabetes: statins for secondary prevention of CVD (IND184)

    This guidance has been updated and replaced by NICE indicator 276.

    Withdrawn indicator

  47. Diabetes: statins for primary prevention of CVD (40 years and over) (IND183)

    This guidance has been updated and replaced by NICE indicator 275.

    Withdrawn indicator

  48. Needle and syringe programmes (PH18)

    This guideline has been updated and replaced by NICE guideline PH52.

    Withdrawn guideline

  49. Workplace health: long-term sickness absence and incapacity to work (PH19)

    This guideline has been updated and replaced by NICE guideline NG146.

    Withdrawn guideline

  50. Four commonly used methods to increase physical activity (PH2)

    This guideline covered four common methods used to increase the population's physical activity levels: brief interventions in primary care, exercise referral schemes, pedometers and community-based walking and cycling programmes. It has been updated and replaced by the following NICE guidelines: Walking and cycling (2012) PH41  Physical activity: brief advice for adults in primary care (2013) PH44  Exercise referral schemes to promote physical activity (2014) PH54 

    Withdrawn guideline